Atlas Trials

Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer

Clinical trial NCT03220932 · UNKNOWN

Trial details

NCT number
NCT03220932
Sponsor
Hospices Civils de Lyon
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Ovarian Epithelial Cancer
Start date
2019-11-30
Primary completion
2022-11-30
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.